Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS [Phase 1]
This clinical trial update notes a Phase 1 study of CD33 FPBMC in patients with measurable residual disease positive acute myeloid leukemia …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax [Phase 2]
Phase 2 trial update evaluating olutasidenib in relapsed IDH1-mutated acute myeloid leukemia patients who have previously received venetocla…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders [Phase 2]
Phase 2 clinical trial evaluating cord blood transplant in children and young adults with blood cancers and select non-malignant disorders; …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL). [Phase 1, Phase 2]
The document updates on an ongoing clinical trial of GYA01 (CART84) for relapsed/refractory acute myeloid leukemia and T-cell acute lymphobl…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML [Phase 1]
Phase 1 trial to assess the safety and tolerability of Ziftomenib in combination with Venetoclax/Azacitidine, Venetoclax alone, or 7+3 with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Tazemetostat and Palbociclib With CPX-351for R/R AML [Phase 1]
A Phase 1 trial from Thomas Jefferson University is evaluating a triple combination of tazemetostat, palbociclib, and CPX-351 for recurrent …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Venetoclax Basket Trial for High Risk Hematologic Malignancies [Phase 1]
A Phase 1 Venetoclax basket trial across multiple high-risk hematologic malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update: venetoclax plus ASTX727 is being studied for relapsed, refractory, or newly diagnosed acute myeloid leukemia …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Venetoclax in Patients With MDS or AML in Relapse After AHSCT [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating venetoclax in patients with myelodysplastic syndromes or acute myeloid leukemia relapsing after all…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Long-Term Follow-up Study
Long-term follow-up study of relapsed/refractory non-Hodgkin lymphoma is currently enrolling by invitation, sponsored by Caribou Biosciences…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
Pfizer is conducting a safety-focused clinical trial of Mylotarg (gemtuzumab ozogamicin) in adults with acute myeloid leukemia, and the stud…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) [Phase 2]
This is a Phase 2 clinical trial update evaluating strategies to reduce graft-versus-host disease in donor blood stem cell transplant patien…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases [NA]
This entry reports an ongoing clinical trial evaluating myeloablative preparative regimens for umbilical cord blood transplantation across s…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML) [Phase 1]
Phase Ib/Phase 1 clinical trial evaluating azacitidine, venetoclax, and allogeneic NK cells in acute myeloid leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating CART123 CAR-T cells with or without the JAK2 inhibitor ruxolitinib in relapsed/refractory acute myeloid leukemia; t…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating combinations of ivosidenib and venetoclax with or without azacitidine in IDH1-mutated hematologic mali…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study of granulocyte-augmented cord blood transplantation for patients with poor-risk…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a three-drug combination of azacitidine, venetoclax, and pevonedistat in newly diagnosed acute myel…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating CMV-MVA Triplex vaccination in HLA-matched related stem cell donors to prevent cytomegalovirus infection i…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Master Framework For Relapse or Refractory Acute Myeloid Leukemia
A clinical trial update describes a master framework for relapse or refractory acute myeloid leukemia and notes that the study is currently …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of the oral decitabine and cedazuridine combination in cancer patients with renal i…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial evaluating ADCLEC.syn1 in adults with acute myeloid leukemia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia [Phase 1]
A Phase 1 clinical trial investigating an optimised CD33 CAR T cell therapy (FL-33) for refractory/relapsed acute myeloid leukemia; currentl…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment [Phase 1]
A phase 1 trial is evaluating the pharmacokinetics and safety of orally administered decitabine in combination with cedazuridine in cancer p…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Ivosidenib as Post-HSCT Maintenance for AML [Phase 2]
Phase 2 trial assessing Ivosidenib as post-transplant maintenance in patients with IDH1-mutant acute myeloid leukemia; the study is currentl…